Add office photos
Employer?
Claim Account for FREE
Moderna
-
No reviews yet
About Moderna
Founded in--
India Employee Count11-50
Global Employee Count1k-5k
HeadquartersMassachusetts, United States
Office Locations
--
Websitemodernatx.com
Primary Industry
Other Industries
--
Are you managing Moderna's employer brand? To edit company information,
claim this page for free
Managing your company's employer brand?
Claim this Company Page for FREE
Report error
Compare Moderna with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | - based on 0 reviews | 3.9/5 based on 1.8k reviews | 3.8/5 based on 676 reviews | 3.5/5 based on 752 reviews |
Highly Rated for | - | Job Security Work-Life balance | No highly rated category | No highly rated category |
Critically Rated for | - | Promotion/Appraisals | Promotion/Appraisals Job Security | Promotion/Appraisals Work Satisfaction Salary & Benefits |
Primary Work Policy | - | Work from office 84% employees reported | Work from office 74% employees reported | Work from office 77% employees reported |
Rating by Women Employees | - no rating available | 3.9 Good rated by 261 women | 3.3 Average rated by 61 women | 3.4 Average rated by 137 women |
Rating by Men Employees | - no rating available | 3.9 Good rated by 1.4k men | 3.8 Good rated by 573 men | 3.6 Good rated by 585 men |
Job Security | - Data not available | 3.8 Good | 3.4 Average | 3.3 Average |
View more
Moderna Salaries
Associate Software Engineer
(2 salaries)
Unlock
₹29.3 L/yr - ₹37.4 L/yr
Fashion Designer
(2 salaries)
Unlock
₹2.7 L/yr - ₹3.5 L/yr
Software Developer
(1 salaries)
Unlock
₹1.3 L/yr - ₹1.6 L/yr
IT Supporter
(1 salaries)
Unlock
₹2.9 L/yr - ₹3.7 L/yr
Moderna News
View all
Alert on 3 Stocks on Sale
- BofA issued bearish ratings on Moderna, Regeneron, and Amgen, stating it was a tough time for Moderna as a vaccine company.
- Super Micro Computer (SMCI) dropped by 8.2% and is at risk of losing its uptrend momentum.
- US Steel (X) dropped by 9.68% due to potential acquisition block by Japan's Nippon Steel, citing national security concerns.
- X and Cleveland-Cliffs (CLF) stock may require a government bailout in the next down cycle.
Baystreet | 11 Dec, 2024
Today's Top Stocks: HSIC, Moderna, Uber and More
- Henry Schein (HSIC) experienced a 7.46% jump after trading in a range at around $70.00.
- Moderna (MRNA) gained 7.22% after a steep selloff last week, attracting the interest of bottom-fishers.
- Uber Technologies (UBER) is facing a downtrend, with hedge funds reducing their positions in the company.
- Root (ROOT) in the insurance segment showed recovery as it bottomed out recently and reported positive earnings per share.
Baystreet | 19 Nov, 2024
Palantir and Disney are Winners, AMAT, OMC and MRNA are Not
- Palantir (PLTR) announced the transfer of its Class A stock to the Nasdaq from the NYSE, causing its stock to rise by 11.14%.
- Disney (DIS) reported revenue growth of 6.3% Y/Y and forecasts high single-digit adjusted EPS growth for FY 2025, leading to a 15% increase in its stock.
- Omnicom Group (OMC) reported a 7% increase in operating income but experienced a 7.79% decline in its stock.
- Moderna (MRNA) faced a decline of 7.34% due to concerns that RFK Jr. leading the U.S. Department of Health and Human Services could impact the vaccine market.
- Moderna's peers, GSK, Novavax (NVAX), and BioNTech (BNTX), also traded lower.
Baystreet | 18 Nov, 2024
Warning: The Post-Election Rally May Fade
- The S&P 500 closed down by 2.08%, testing the lower channel of its uptrend.
- Trump's controversial appointments and the Federal Reserve's latest commentary might accelerate the post-election rally's fade.
- Healthcare stocks, particularly Merck, GSK, and Moderna, may continue their sell-off if the government is less supportive of vaccines.
- Traders took profits in the chip sector, leading to lower prices for Broadcom, Micron, AMD, and Intel due to concerns about stretched valuations.
Baystreet | 18 Nov, 2024
Vaccine Stocks Plunge On News Of RFK Jr. Health Nomination
- Shares of vaccine makers like Moderna and Pfizer plunged after news of Robert F. Kennedy Jr.'s nomination as head of the U.S. Department of Health and Human Services.
- Kennedy, a vocal vaccine skeptic, has criticized Covid-19 vaccines and wants to overhaul the FDA.
- His nomination has raised concerns about the future of routine immunizations in the U.S.
- Moderna's stock is down 67% this year, while Pfizer's stock has declined 17%.
Baystreet | 18 Nov, 2024
Vaccine Stocks Slide as Trump Taps RFK Jr. for HHS
- Vaccine stocks Moderna and Novavax have dropped over 30% in the last month.
- Concerns arise as Robert F. Kennedy Jr. is nominated by Trump to head HHS.
- Kennedy's vocal criticism of vaccines adds uncertainty to the future of pharma stocks.
- Investors fear new regulatory hurdles for vaccine companies under Kennedy's influence.
Bitcoinsensus | 16 Nov, 2024
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
- Vaccine stocks have tumbled since Trump appointed vaccine skeptic Robert F. Kennedy Jr. to health secretary.
- Moderna, Pfizer, and GSK saw sharp losses in their stock prices.
- The negative impact also spread to US-exposed European healthcare stocks.
- Kennedy's appointment raises concerns about the future of vaccine regulation and policies.
Insider | 16 Nov, 2024
Pharma shares hit as Trump picks RFK Jr to lead health department
- Investors in pharmaceutical companies are selling off stock after Donald Trump nominated the anti-vaccine activist Robert F Kennedy Jr to lead the US Department of Health and Human Services.
- RFK Jr has embraced numerous health-related conspiracy theories, including linking vaccines to autism and claiming that some antidepressants are linked to school shootings.
- Shares in major pharmaceutical companies, such as Moderna, AstraZeneca, and GSK, fell following the announcement.
- RFK Jr's nomination has drawn widespread criticism, with concerns raised about the potential impact on public health infrastructure and vaccine distribution systems.
Guardian | 15 Nov, 2024
Vaccine maker stocks fall in US after Trump picks anti-vaccine activist RFK Jr as health secretary
- Covid vaccine maker stocks fell in the US after President Trump selected anti-vaccine activist RFK Jr as health secretary.
- Moderna Inc. dropped 5.6% and Pfizer Inc. dropped 2.6% in regular trading.
- BioNTech SE, Pfizer's Covid vaccine partner, sank 7% while Novavax Inc. dipped 7%.
- Public health officials have expressed concerns about the risks of curtailing vaccination efforts.
HinduBusinessLine | 15 Nov, 2024
Stocks on Sale: CVS Health, Moderna, and Albemarle
- CVS Health (CVS) saw a short-lived rally after its Q3 results showed a rise in revenue.
- Moderna (MRNA) closed at a 52-week low, despite beating earnings and revenue expectations.
- Albemarle (ALB), a lithium miner, is trading below its high for the year as investors wait for its 2025 outlook.
- Albemarle expects a turnaround in 2025, benefiting from equity earnings and cost reductions.
Baystreet | 14 Nov, 2024
Powered by
Compare Moderna with
LifeCell International
3.4
Praj Industries
4.1
Serum Institute of India
4.2
Bharat Biotech International
3.1
Transasia Bio-Medicals
3.2
Indian Immunologicals
4.1
Jubilant Biosys
3.8
Avantor
3.7
Novozymes South Asia
4.1
Shantha Biotechnics
4.7
dsm-firmenich
4.1
Kemin Industries
4.4
Sartorius Stedim India
3.9
Pall Corporation
4.4
MilliporeSigma
4.0
Biofi Medical Healthcare
2.9
Biogen
4.9
Mapmygenome- Genetic Testing/Counseling
3.4
EMINENT BIOSCIENCES
5.0
QIAGEN
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Moderna
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Biocon Biologics
Biotechnology
3.5
• 752 reviews
Panacea Biotec
Biotech & Life sciences, Biotechnology
3.8
• 676 reviews
LifeCell International
Biotech & Life sciences, Internet, Biotechnology
3.4
• 606 reviews
Praj Industries
Biotech & Life sciences, Biotechnology
4.1
• 508 reviews
Serum Institute of India
Biotechnology
4.2
• 409 reviews
Bharat Biotech International
Biotech & Life sciences, Manufacturing, Biotechnology
3.1
• 409 reviews
Transasia Bio-Medicals
Industrial Machinery, Biotechnology
3.2
• 334 reviews
Indian Immunologicals
Biotech & Life sciences, Manufacturing, Biotechnology
4.1
• 332 reviews
Jubilant Biosys
Financial Services, Biotechnology
3.8
• 276 reviews
Avantor
Biotechnology, Healthcare, Pharma
3.7
• 235 reviews
Novozymes South Asia
Food Processing, Manufacturing, Fashion & Textile, Biotechnology
4.1
• 176 reviews
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
